| 4 | Statement of changes in beneficial owner... | Mcclure Matthew W. | Latham & Watkins Llp (filing Agent) /fa | 03/04/2024 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 03/04/2024 | |
| 4 | Statement of changes in beneficial owner... | Mcclure Matthew W. | Latham & Watkins Llp (filing Agent) /fa | 02/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 02/28/2024 | |
| 4 | Statement of changes in beneficial owner... | Mcclure Matthew W. | Latham & Watkins Llp (filing Agent) /fa | 09/12/2023 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Latham & Watkins Llp (filing Agent) /fa | 09/12/2023 | |
| 4 | Statement of changes in beneficial owner... | Mcclure Matthew W. | Broadridge Financial Solutions, Inc./fa /fa | 03/17/2023 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Broadridge Financial Solutions, Inc./fa /fa | 03/17/2023 | |
| 4 | Statement of changes in beneficial owner... | Aligos Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 07/11/2022 | |
| 4 | Statement of changes in beneficial owner... | Mcclure Matthew W. | Broadridge Financial Solutions, Inc./fa /fa | 07/11/2022 | |
| Load More |